• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新的社区卫生工作者工具在资源有限的环境下,在评估抗逆转录病毒治疗资格方面优于世界卫生组织的临床分期。

A novel community health worker tool outperforms WHO clinical staging for assessment of antiretroviral therapy eligibility in a resource-limited setting.

机构信息

*Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom; †TB and HIV Group, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi; ‡Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom; §Department of Pathology and Laboratory Medical Sciences, College of Medicine, University of Malawi, Blantyre, Malawi; ‖Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom; and ¶HIV Department, Ministry of Health, Lilongwe, Malawi.

出版信息

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):e74-8. doi: 10.1097/QAI.0b013e3182a20e74.

DOI:10.1097/QAI.0b013e3182a20e74
PMID:23846567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3966510/
Abstract

The accuracy of a novel community health worker antiretroviral therapy eligibility assessment tool was examined in community members in Blantyre, Malawi. Nurses independently performed World Health Organization (WHO) staging and CD4 counts. One hundred ten (55.6%) of 198 HIV-positive participants had a CD4 count of <350 cells per cubic millimeter. The community health worker tool significantly outperformed WHO clinical staging in identifying CD4 count of <350 cells per cubic millimeter in terms of sensitivity (41% vs. 19%), positive predictive value (75% vs. 68%), negative predictive values (53% vs. 47%), and area under the receiver-operator curve (0.62 vs. 0.54; P = 0.017). Reliance on WHO staging is likely to result in missed and delayed antiretroviral therapy initiation.

摘要

研究人员在马拉维布兰太尔的社区成员中检验了一种新型社区卫生工作者抗逆转录病毒治疗资格评估工具的准确性。护士独立进行世界卫生组织(WHO)分期和 CD4 计数。在 198 名 HIV 阳性参与者中,有 110 名(55.6%)的 CD4 计数<350 个细胞/立方毫米。就敏感性(41%对 19%)、阳性预测值(75%对 68%)、阴性预测值(53%对 47%)和接收者操作特征曲线下面积(0.62 对 0.54;P=0.017)而言,社区卫生工作者工具在识别 CD4 计数<350 个细胞/立方毫米方面显著优于 WHO 临床分期。依赖 WHO 分期可能导致抗逆转录病毒治疗的机会错失和延迟。

相似文献

1
A novel community health worker tool outperforms WHO clinical staging for assessment of antiretroviral therapy eligibility in a resource-limited setting.一种新的社区卫生工作者工具在资源有限的环境下,在评估抗逆转录病毒治疗资格方面优于世界卫生组织的临床分期。
J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):e74-8. doi: 10.1097/QAI.0b013e3182a20e74.
2
WHO HIV clinical staging or CD4 cell counts for antiretroviral therapy eligibility assessment? An evaluation in rural Rakai district, Uganda.用于抗逆转录病毒治疗资格评估的世界卫生组织艾滋病毒临床分期或CD4细胞计数?乌干达拉凯区农村地区的一项评估。
AIDS. 2007 May 31;21(9):1208-10. doi: 10.1097/QAD.0b013e32810c8dce.
3
CD4+ cell count testing more effective than HIV disease clinical staging in identifying pregnant and postpartum women eligible for antiretroviral therapy in resource-limited settings.CD4+ 细胞计数检测比 HIV 疾病临床分期更能有效识别资源有限环境下适合接受抗逆转录病毒治疗的孕妇和产后妇女。
J Acquir Immune Defic Syndr. 2010 Nov;55(3):404-10. doi: 10.1097/QAI.0b013e3181e73f4b.
4
Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.在资源匮乏地区,与单纯临床监测相比,采用 HIV 病毒载量、CD4 细胞计数监测联合临床评估的方法进行抗逆转录病毒治疗的成本效益分析(Stratall ANRS 12110/ESTHER)
Lancet Infect Dis. 2013 Jul;13(7):577-86. doi: 10.1016/S1473-3099(13)70073-2. Epub 2013 Apr 18.
5
Estimating the need for antiretroviral treatment and an assessment of a simplified HIV/AIDS case definition in rural Malawi.估算马拉维农村地区抗逆转录病毒治疗需求并评估简化的艾滋病毒/艾滋病病例定义
AIDS. 2007 Nov;21 Suppl 6(Suppl 6):S105-13. doi: 10.1097/01.aids.0000299417.69432.65.
6
Suboptimal patterns of provider initiated HIV testing and counselling, antiretroviral therapy eligibility assessment and referral in primary health clinic attendees in Blantyre, Malawi.马拉维布兰太尔初级保健诊所就诊者中提供方启动的 HIV 检测和咨询、抗逆转录病毒治疗资格评估和转介的服务提供模式不佳。
Trop Med Int Health. 2012 Apr;17(4):507-17. doi: 10.1111/j.1365-3156.2011.02946.x. Epub 2012 Feb 1.
7
Interleukin-2 therapy in patients with HIV infection.白细胞介素-2疗法用于HIV感染患者。
N Engl J Med. 2009 Oct 15;361(16):1548-59. doi: 10.1056/NEJMoa0903175.
8
Screening HIV-infected adults in Malawi for anaemia: impact on eligibility for antiretroviral therapy.在马拉维对感染艾滋病毒的成年人进行贫血筛查:对抗逆转录病毒疗法资格的影响。
Int J STD AIDS. 2013 Jun;24(6):449-53. doi: 10.1177/0956462412472832. Epub 2013 Jun 18.
9
Integration and task shifting for TB/HIV care and treatment in highly resource-scarce settings: one size may not fit all.在资源极度匮乏的环境中整合和任务转移以进行结核病/艾滋病护理和治疗:一种模式可能并不适合所有情况。
J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):e110-7. doi: 10.1097/01.qai.0000434954.65620.f3.
10
Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy.早期抗逆转录病毒治疗可增强 CD4+ T 细胞恢复。
N Engl J Med. 2013 Jan 17;368(3):218-30. doi: 10.1056/NEJMoa1110187.

引用本文的文献

1
Cost and quality of life analysis of HIV self-testing and facility-based HIV testing and counselling in Blantyre, Malawi.马拉维布兰太尔地区艾滋病毒自我检测及基于医疗机构的艾滋病毒检测与咨询的成本及生活质量分析
BMC Med. 2016 Feb 19;14:34. doi: 10.1186/s12916-016-0577-7.
2
Diagnostic accuracy of the WHO clinical staging system for defining eligibility for ART in sub-Saharan Africa: a systematic review and meta-analysis.世界卫生组织临床分期系统在撒哈拉以南非洲地区确定抗逆转录病毒治疗资格方面的诊断准确性:一项系统评价和荟萃分析
J Int AIDS Soc. 2014 Jun 12;17(1):18932. doi: 10.7448/IAS.17.1.18932. eCollection 2014.

本文引用的文献

1
The next generation of the World Health Organization's global antiretroviral guidance.下一代世界卫生组织全球抗逆转录病毒指南。
J Int AIDS Soc. 2013 Jun 30;16(1):18757. doi: 10.7448/IAS.16.1.18757.
2
Barriers and facilitators to linkage to ART in primary care: a qualitative study of patients and providers in Blantyre, Malawi.在初级保健中进行抗逆转录病毒治疗(ART)的衔接的障碍和促进因素:来自马拉维布兰太尔的患者和提供者的定性研究。
J Int AIDS Soc. 2012 Dec 31;15(2):18020. doi: 10.7448/IAS.15.2.18020.
3
Determinants and consequences of failure of linkage to antiretroviral therapy at primary care level in Blantyre, Malawi: a prospective cohort study.马拉维布兰太尔基层医疗点抗逆转录病毒治疗失败的决定因素和后果:一项前瞻性队列研究。
PLoS One. 2012;7(9):e44794. doi: 10.1371/journal.pone.0044794. Epub 2012 Sep 11.
4
Suboptimal patterns of provider initiated HIV testing and counselling, antiretroviral therapy eligibility assessment and referral in primary health clinic attendees in Blantyre, Malawi.马拉维布兰太尔初级保健诊所就诊者中提供方启动的 HIV 检测和咨询、抗逆转录病毒治疗资格评估和转介的服务提供模式不佳。
Trop Med Int Health. 2012 Apr;17(4):507-17. doi: 10.1111/j.1365-3156.2011.02946.x. Epub 2012 Feb 1.
5
Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study.基于即时检测 CD4 细胞计数的护理点测试对初级卫生保健诊所患者保留率和抗逆转录病毒治疗启动率的影响:一项观察性队列研究。
Lancet. 2011 Oct 29;378(9802):1572-9. doi: 10.1016/S0140-6736(11)61052-0. Epub 2011 Sep 25.
6
Validation of World Health Organisation HIV/AIDS clinical staging in predicting initiation of antiretroviral therapy and clinical predictors of low CD4 cell count in Uganda.验证世界卫生组织 HIV/AIDS 临床分期在预测乌干达开始抗逆转录病毒治疗和 CD4 细胞计数低的临床预测因素中的作用。
PLoS One. 2011 May 12;6(5):e19089. doi: 10.1371/journal.pone.0019089.
7
New insights into HIV-1-primary skin disorders.HIV-1 原发性皮肤疾病的新见解。
J Int AIDS Soc. 2011 Jan 24;14:5. doi: 10.1186/1758-2652-14-5.
8
A primary care level algorithm for identifying HIV-infected adolescents in populations at high risk through mother-to-child transmission.一种主要针对母婴传播高危人群中 HIV 感染青少年的初级保健水平算法。
Trop Med Int Health. 2011 Mar;16(3):349-55. doi: 10.1111/j.1365-3156.2010.02708.x. Epub 2010 Dec 22.
9
CD4+ cell count testing more effective than HIV disease clinical staging in identifying pregnant and postpartum women eligible for antiretroviral therapy in resource-limited settings.CD4+ 细胞计数检测比 HIV 疾病临床分期更能有效识别资源有限环境下适合接受抗逆转录病毒治疗的孕妇和产后妇女。
J Acquir Immune Defic Syndr. 2010 Nov;55(3):404-10. doi: 10.1097/QAI.0b013e3181e73f4b.
10
Cost-effectiveness of routine and low-cost CD4 T-cell count compared with WHO clinical staging of HIV to guide initiation of antiretroviral therapy in resource-limited settings.在资源有限的情况下,与世界卫生组织(WHO)的临床分期相比,常规和低成本 CD4 细胞计数对指导开始抗逆转录病毒治疗的成本效益。
AIDS. 2010 Jul 31;24(12):1887-95. doi: 10.1097/QAD.0b013e32833b25ed.